A rare case of group A streptococcal toxic‐shock syndrome in a postpartum adolescent leading to multi‐organ failure by Cortez Granados, Samuel et al.
Clin Case Rep. 2020;8:793–797.    | 793wileyonlinelibrary.com/journal/ccr3
1 |  INTRODUCTION
Teenage pregnancy is not uncommon, but given the age of the 
patient, experience, and competency among medical provid-
ers varies. Here, we describe a 15-year-old female on postpar-
tum day 3 who was admitted to the pediatric ICU with fever 
and hemodynamic instability from septic shock. Upon admis-
sion, the patient required intubation, vasoactive agents, and 
antibiotics. An emergent hysterectomy was done, and cultures 
grew group A streptococcus (GAS). On day 3 of admission, 
she developed subsequent multi-organ failure. This rare com-
plication may be so fulminant that the diagnosis is often made 
too late to provide lifesaving treatment. GAS toxic-shock syn-
drome (TSS) should always be part of the differential diagno-
sis when a pregnant or postpartum patient presents with septic 
shock. While this is a rare occurrence in teenage pregnancy, 
observed is a gap in care of bridging adolescents into adult 
medicine, especially in obstetrics and postpartum care.
Received: 8 August 2019 | Revised: 30 December 2019 | Accepted: 21 January 2020
DOI: 10.1002/ccr3.2799  
C A S E  R E P O R T
A rare case of group A streptococcal toxic-shock syndrome in a 
postpartum adolescent leading to multi-organ failure
Samuel Cortez Granados1  |   Jonathan Batsch1 |   Asona Lui1 |   Jacob Hessman1 |   
Nika Gloyeske2 |   Apurva Panchal3
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
1Department of Pediatrics, University of 
Kansas Medical Center, Kansas City, KS, 
USA
2Department of Pathology and Laboratory 
Medicine, University of Kansas Medical 
Center, Kansas City, KS, USA
3Department of Pediatric Critical Care 
Medicine, University of Kansas Medical 
Center, Kansas City, KS, USA
Correspondence
Samuel Cortez Granados, Pediatric 
Resident, University of Kansas Medical 
Center, Kansas City, KS, USA.
Email: scortezgranados@kumc.edu
Funding information
The article processing charges related to the 
publication of this article were supported 
by The University of Kansas (KU) One 
University Open Access Author Fund 
sponsored jointly by the KU Provost, KU 
Vice Chancellor for Research & Graduate 
Studies, and KUMC Vice Chancellor 
for Research and managed jointly by the 
Libraries at the Medical Center and KU – 
Lawrence.”
Abstract
Teenage pregnancy is not uncommon, but given the age of the patient, experience, 
and competency among medical providers varies. While toxic-shock syndrome from 
group A streptococcus is rare in teenage pregnancy, observed is a gap in care of 
bridging.
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Toxic-shock syndrome is a rare, but life-threatening ill-
ness characterized by multi-organ failure. The known causes 
of TSS are Staphylococcus aureus and group A streptococ-
cus. These bacteria release super antigens that cause massive 
release of inflammatory mediators leading to capillary leak, 
shock, and tissue damage. In a recent study, pregnant and post-
partum women were shown to have up to a 20-fold increase 
risk of developing TSS.1 The annual US incidence of GAS 
infection in postpartum women is 5 per 100 000.2 Of these 
women, only a small percent will develop TSS and sequential 
organ failure requiring immediate intervention. When TSS 
from GAS develops within four days of delivery, the mortality 
rate approaches 60%.3 Here, we report a case of a 15-year-old 
girl who developed GAS TSS 3 days postpartum, complicated 
by multi-organ failure and required emergent hysterectomy. 
To the best of our knowledge, this is the first case report of an 
adolescent developing postpartum GAS TSS.
2 |  CASE PRESENTATION
A 15-year-old G1P0 Caucasian female with a past medical 
history of well-controlled asthma and esophageal reflux re-
cently delivered a baby girl vaginally at 39-week and 3-day 
gestational age. Her pregnancy was complicated by tobacco 
use, preeclampsia, and urinary tract infection at time of de-
livery due to GAS. Prenatal testing for infectious etiologies 
was unremarkable, including human papilloma virus (HPV), 
human immunodeficiency virus (HIV), rapid plasma reagin 
(RPR) for syphilis, and group B streptococci (GBS). Per 
the rural hospital, foul smelling, meconium-tinged amniotic 
fluid was noted at the time of delivery, followed by vaginal 
placental extraction. Mother's vital signs were within normal 
limits. The baby was febrile at birth with a temperature of 
101.6°F (38.6°C) and was transferred to the neonatal ICU 
for broad-spectrum IV antibiotics. The baby's course was 
noncomplicated. On postpartum day 3, the mother developed 
fever, acute onset abdominal and chest pain, tachycardia, 
and significant hypotension. She was diagnosed with septic 
shock and was transferred to our pediatric ICU.
Upon presentation, she was nonresponsive to verbal com-
mands, febrile, and had a heart rate of 144 beats/min, blood 
pressure of 85/42 mm Hg, and respiratory rate of 23 breaths/
min. Aggressive fluid resuscitation with a 2 L isotonic fluid 
was ineffective, and she was started on a continuous norepi-
nephrine 0.15 mcg/kg/min infusion. Subsequent hypoxemia 
led to intubation, and she was placed on invasive positive 
pressure ventilation shortly after arrival. Phenylephrine 
150 mcg/kg/min and vasopressin 0.4 units/h were added to 
optimize perfusion. Initial laboratory studies revealed mild 
leukocytosis with WBC of 12.7 K/UL, hemoglobin of 8.4 g/
dL, platelet count of 57 000/UL, lactate of 6.6 mmol/L, se-
verely elevated CRP of 39.51 mg/dL and procalcitonin of 
11.6 ng/mL, INR of 1.6 (normal = 0.8-1.2), and a signifi-
cantly elevated D-dimer of 99  000  ng/mL (normal value 
<50  years old is <500  ng/mL). She also had profound 
metabolic acidosis. Clinical picture and laboratories were 
consistent with septic shock and secondary disseminated in-
travascular coagulopathy. She was started on clindamycin, 
vancomycin, and zosyn for broad-spectrum coverage. The 
patient received a unit of blood and fresh frozen plasma. 
Obstetrics and Gynecology (OBGYN) was consulted and 
determined that her clinical picture was most consistent 
with endometritis.
CT imaging was done and confirmed the diagnosis of 
endometritis with enlarged uterus. Within 24  hours upon 
arrival, she was taken to the operative room for exploratory 
laparotomy as her clinical condition continued deteriorating. 
A grossly edematous uterus (Figure 1) with massive necrosis, 
more than 75% of endometrium, was observed. It was decided 
at that time to perform a total abdominal hysterectomy with 
salpingectomy. Uterine tissue was sent for cultures, which 
along with blood and urine cultures came back positive for 
group A streptococci. Her antibiotics were subsequently nar-
rowed to a 14-day course of IV clindamycin and penicillin in 
accordance with GAS endometritis guidelines. Final surgical 
pathology revealed an enlarged, friable endometrium with 
significant necrosis and ischemia (Figures 2 and 3) consistent 
with septic endometritis.
F I G U R E  1  CT abdomen and pelvis, sagittal view. HMG 
(28 cm), SMG (17.5 cm), hepatic steatosis, small/trace amounts of 
ascites, enlarged uterus, and tiny pockets of air in the endometrial 
canal
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On day 3 of admission, she developed multi-organ failure 
including acute respiratory distress syndrome and cardiovas-
cular dysfunction leading to cardiogenic shock. The markers 
of cardiac injury were elevated with B-type natriuretic pep-
tide (BNP) reaching a peak of 1724 pg/mL (normal value is 
0-100 pg/mL) and troponin I reaching levels of 49.3 ng/mL 
(normal value 0.0-0.05 ng/mL). Electrocardiography showed 
diffuse ST elevations (Figure  4). Echocardiogram revealed 
cardiomyopathy with severely diminished cardiac functions 
and a left ventricular ejection fraction of 25%. Due to con-
cerns for coronary artery dissection, the patient was taken 
for cardiac catheterization, which was normal. All vasoactive 
agents were weaned down as tolerated, and she was placed 
on an intravenous milrinone infusion at 0.5 mcg/kg/min for 
her diminished cardiac function. She was started on intrave-
nous hydrocortisone as we suspected her cardiomyopathy 
was likely the result of significant systemic inflammation. In 
addition to large dose steroid, five doses of 1 g of intravenous 
immunoglobulin (IVIG) were given to help control the sys-
temic spread of inflammatory processes.
Over the course of two weeks, her cardiac function im-
proved with milrinone, hydrocortisone, and IVIG. She was 
gradually weaned off all vasopressors (Table S1 for timeline 
and dosage of each vasopressor), and her cardiac functions 
and tissue perfusions stabilized. BNP, troponin I, lactate, 
CRP, and D-dimer slowly normalized. She was eventually 
extubated to high-flow nasal cannula and then slowly to 
room air. Her milrinone was eventually switched to lisino-
pril and carvedilol. She completed her fourteen-day course of 
clindamycin and penicillin G. Her last echocardiogram prior 
to discharge demonstrated a normal LVEF of 73%. After 
17 days of hospitalization, she was discharged in stable con-
dition with outpatient follow-up in pediatric cardiology and 
OBGYN.
3 |  DISCUSSION
Puerperal infections cause morbidity in 5%-10% of all preg-
nant women with over 75 000 deaths globally each year.4 Most 
deaths occur in countries with poor prenatal care. Sepsis dur-
ing pregnancy is infrequent. Less than 1% of pregnant women 
get bacteremia, and of these, only a handful develops sepsis 
F I G U R E  2  Gross examination of the uterus upon removal. 
Examination is consistent with the size of a postpartum uterus. Marked 
necrotic changes in the endometrium can be visualized, along with 
disruption of normal uterine architecture, all consistent with GAS 
endometritis
F I G U R E  3  A, Fallopian tubes. Acute inflammatory infiltration 
into the fallopian tube plicae (H&E, 200×). B, Uterus. Marked acute 
and chronic inflammation intermixed with fibrin and necrosis of the 
endometrial lining overlying rare preserved endometrial glands with 
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and septic shock (0.01% of all deliveries).2 Nevertheless, 
they remain among leading causes of pregnancy-associated 
death worldwide. GAS infection is one of the fatal infections 
that occurs during pregnancy and the postpartum period. 
Severe sepsis from GAS still carries a substantial amount of 
maternal mortality (40%-60%) in developed countries.3 The 
diagnosis of streptococcal toxic-shock syndrome (STSS) cri-
teria was first published in 1993 and includes the isolation 
of group A streptococcus (GAS) from a sterile or nonster-
ile site associated with clinical signs of severity. Findings of 
GAS in postpartum women can be nonspecific which results 
in delayed treatment. By the time the diagnosis of GAS TSS 
is made, the disease can be advanced and involve multiple 
organs, as in this case. The management can be divided into 
supportive care, early targeted antibacterial therapy (includ-
ing intravenous clindamycin), surgical removal of infected 
nidus, and potential use of IVIG.
GAS is a gram-positive, beta-hemolytic streptococcus. It 
colonizes human skin and mucus membranes but rarely re-
sides in the vagina. The vaginal colonization rate of GAS in 
low-risk pregnancies is 0.03%.5 This low prevalence of colo-
nization is why it is not normally screened for during routine 
prenatal care. GAS causes a wide array of disease including 
cellulitis, pharyngitis, necrotizing fasciitis, and toxic-shock 
syndrome. Due to its lethal nature, all vaginal cultures pos-
itive for GAS during pregnancy should be considered a 
true infection and be treated appropriately with antibiotics. 
Invasive GAS usually occurs within 2-3 days of delivery and 
is characterized by high-grade fever, chills, and minimal to 
no abdominal or uterine tenderness.6 There may be scant, 
nonpurulent lochia. Although most GAS infections are asso-
ciated with bacteremia without focus, endometritis remains 
one of the top findings of invasive GAS.7
Damage to the cardiac tissue, as seen in our patient, is 
a defining feature of septic shock. Typically, the signs of 
cardiac insult present as soon as 48 hours after sepsis onset. 
The massive release of systemic cytokines, including tissue 
necrosis factor-alpha (TNF-alpha), seen in sepsis results in 
myocardial dysfunction and necrosis.8 Pregnancy causes 
many changes in cardiac function but left ventricular function 
and ejection fraction are usually unchanged. The use of mil-
rinone provided inotropic support and reduced strain on the 
heart by decreasing afterload. IVIG has been recommended 
as additional therapy by promoting an anti-inflammatory re-
sponse and neutralizing toxins.9 Evidence of this offering ad-
ditional benefit to GAS TSS is lacking statistical significance 
in clinical trials.10 Laboratory evidence in favor of the use of 
IVIG in STSS includes the presence of neutralizing antibod-
ies to streptococcal superantigen toxins in IVIG. In addition, 
plasma from patients with STSS who have been treated with 
IVIG can inhibit superantigen-induced T-cell proliferation 
and production of cytokines in vitro. IVIG has multiple other 
anti-inflammatory properties, and the specific mechanism 
underlying its potential beneficial effect in STSS is unknown. 
Much of the known use of IVIG is on patients with viral dis-
eases. The decision to use IVIG for this patient was made and 
rather or not it provided benefit cannot be concluded from 
this one case alone but here we describe its use with a posi-
tive outcome. The patient was discharged with lisinopril and 
carvedilol to maintain the reduction in cardiac workload and 
prevent cardiac remodeling. The cardiac damage sustained 
has been shown to be fully reversible if treated promptly.11
Standard treatment of GAS TSS in pregnancy includes 
aggressive fluid management, vasopressors, and inotropes to 
maintain adequate blood pressure and perfusion, antibiotics, 
and blood products as needed. Penicillin remains the drug of 
choice for GAS infection.12 Because of its potent inhibitory 
effect on toxin production and additive antimicrobial activity, 
clindamycin is recommended for severe invasive GAS infec-
tion.13 The combination of penicillin and clindamycin has 
been associated with improved outcomes in severe invasive 
GAS cases. When GAS is found to have colonized the uterus, 
emergent hysterectomy is recommended to remove the source 
of infection. Given the young age of the patient, the risks and 
benefits of this procedure were weighed carefully prior to 
the operation. Examination during exploratory laparotomy 
revealed significant damage to the uterus and indicated the 
need for emergent hysterectomy. The patient's full recovery 
F I G U R E  4  EKG with sinus 
tachycardia and inferior limb ST segment 
elevation and lateral limb lead ST segment 
depression
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was facilitated by the staff's ability to provide quick and ap-
propriate management. However, better outcomes could have 
been achieved had treatment been initiated at an early time-
frame. Presented here was a detailed case of GAS TSS and 
its complications in an adolescent. The goal of this paper was 
to improve outcomes and avoid serious complications for this 
vulnerable population by assisting medical professionals in 
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